Advertisement

Colorectal Cancer: Metastatic (Palliation)

  • Elisabeth C. McLemore
  • Sonia Ramamoorthy
Chapter

Abstract

Approximately 20% of colorectal cancer patients present with established distant metastases.1 Metastases are often detectable with noninvasive imaging such as CT scan and MRI that are performed for staging of cancer. A diagnosis of stage IV disease then allows for appropriate operative and oncologic planning. Among these patients there is enormous heterogeneity with respect to sites of disease, extent of disease, symptoms, performance status, and comorbidities. The clinical spectrum at the time of diagnosis ranges from the asymptomatic patient with a single metastatic lesion to the rapidly deteriorating patient with colon obstruction and advanced, multiorgan metastases. While treatment algorithms may exist for some forms of metastatic disease such as a solitary liver lesion, others are still being defined.

References

  1. 1.
    Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55(1):10–30.PubMedGoogle Scholar
  2. 2.
    O’Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2004;96(19):1420–5.PubMedGoogle Scholar
  3. 3.
    Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. J Clin Oncol. 1992;10(6):904–11.Google Scholar
  4. 4.
    Scheithauer W, Rosen H, Kornek GV, Sebesta C, Depisch D. Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. BMJ. 1993;306(6880):752–5.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Tournigand C, Andre T, Achille E, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol. 2004;22(2):229–37.PubMedGoogle Scholar
  6. 6.
    Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350(23):2335–42.PubMedGoogle Scholar
  7. 7.
    Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57–70.PubMedGoogle Scholar
  8. 8.
    Woodhouse EC, Chuaqui RF, Liotta LA. General mechanisms of metastasis. Cancer. 1997;80(8 Suppl):1529–37.PubMedGoogle Scholar
  9. 9.
    Fidler IJ. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res. 1990;50(19):6130–8.PubMedGoogle Scholar
  10. 10.
    Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. Cancer Res. 1986;46(2):467–73.PubMedGoogle Scholar
  11. 11.
    Hynes RO. Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants – or both? Cell. 2003;113(7):821–3.PubMedGoogle Scholar
  12. 12.
    Bogenrieder T, Herlyn M. Axis of evil: molecular mechanisms of cancer metastasis. Oncogene. 2003;22(42):6524–36.PubMedGoogle Scholar
  13. 13.
    Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2002;2(8):563–72.PubMedGoogle Scholar
  14. 14.
    Messick CA, Church JM, Liu X, Ting AH, Kalady MF. Stage III colorectal cancer: molecular disparity between primary cancers and lymph node metastates. Ann Surg Oncol. 2010;17(2):425–31.PubMedGoogle Scholar
  15. 15.
    Shevde LA, Welch DR. Metastasis suppressor pathways – an evolving paradigm. Cancer Lett. 2003;198(1):1–20.PubMedGoogle Scholar
  16. 16.
    Chin BB, Wahl RL. 18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies. Gut. 2003;52 Suppl 4:iv23–9.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Deans GT, Krukowski ZH, Irwin ST. Malignant obstruction of the left colon. Br J Surg. 1994;81(9):1270–6.PubMedGoogle Scholar
  18. 18.
    Phillips RK, Hittinger R, Fry JS, Fielding LP. Malignant large bowel obstruction. Br J Surg. 1985;72(4):296–302.PubMedGoogle Scholar
  19. 19.
    Van Hooft JE, Bemelman WA, Fockens P. A study of the value of colonic stenting as a bridge to elective surgery for the management of acute left-sided malignant colonic obstruction: the STENT-IN 2 study. Ned Tijdschr Geneeskd. 2007;151:1249–51.PubMedGoogle Scholar
  20. 20.
    Vemulapalli R, Lara LF, Sreenarasimhaiah J, Harford WV, Siddiqui AA. A comparison of palliative stenting or emergent surgery for obstructing incurable colon cancer. Dig Dis Sci. 2010;55(6):1732–7.PubMedGoogle Scholar
  21. 21.
    Gandrup P, Lund L, Balslev I. Surgical treatment of acute malignant large bowel obstruction. Eur J Surg. 1992;158(8):427–30.PubMedGoogle Scholar
  22. 22.
    Loizou LA, Grigg D, Boulos PB, Bown SG. Endoscopic Nd:YAG laser treatment of rectosigmoid cancer. Gut. 1990;31(7):812–6.PubMedPubMedCentralGoogle Scholar
  23. 23.
    Daneker Jr GW, Carlson GW, Hohn DC, Lynch P, Roubein L, Levin B. Endoscopic laser recanalization is effective for prevention and treatment of obstruction in sigmoid and rectal cancer. Arch Surg. 1991;126(11):1348–52.PubMedGoogle Scholar
  24. 24.
    Mandava N, Petrelli N, Herrera L, Nava H. Laser palliation for colorectal carcinoma. Am J Surg. 1991;162(3):212–4;discussion 5.PubMedGoogle Scholar
  25. 25.
    Brunetaud JM, Maunoury V, Cochelard D. Lasers in rectosigmoid tumors. Semin Surg Oncol. 1995;11(4):319–27.PubMedGoogle Scholar
  26. 26.
    Gevers AM, Macken E, Hiele M, Rutgeerts P. Endoscopic laser therapy for palliation of patients with distal colorectal carcinoma: analysis of factors influencing long-term outcome. Gastrointest Endosc. 2000;51(5):580–5.PubMedGoogle Scholar
  27. 27.
    Salvati EP, Rubin RJ, Eisenstat TE, Siemons GO, Mangione JS. Electrocoagulation of selected carcinoma of the rectum. Surg Gynecol Obstet. 1988;166(5):393–6.PubMedGoogle Scholar
  28. 28.
    Eisenstat TE, Oliver GC. Electrocoagulation for adenocarcinoma of the low rectum. World J Surg. 1992;16(3):458–62.PubMedGoogle Scholar
  29. 29.
    Khot UP, Lang AW, Murali K, Parker MC. Systematic review of the efficacy and safety of colorectal stents. Br J Surg. 2002;89(9):1096–102.PubMedGoogle Scholar
  30. 30.
    Law WL, Choi HK, Lee YM, Chu KW. Palliation for advanced malignant colorectal obstruction by self-expanding metallic stents: prospective evaluation of outcomes. Dis Colon Rectum. 2004;47(1):39–43.PubMedGoogle Scholar
  31. 31.
    Athreya S, Moss J, Urquhart G, Edwards R, Downie A, Poon FW. Colorectal stenting for colonic obstruction: the indications, complications, effectiveness and outcome – 5-year review. Eur J Radiol. 2006;60(1):91–4.PubMedGoogle Scholar
  32. 32.
    Dronamraju SS, Ramamurthy S, Kelly SB, Hayat M. Role of self-expanding metallic stents in the management of malignant obstruction of the proximal colon. Dis Colon Rectum. 2009;52(9):1657–61.PubMedGoogle Scholar
  33. 33.
    Rosen SA, Buell JF, Yoshida A, et al. Initial presentation with stage IV colorectal cancer: how aggressive should we be? Arch Surg. 2000;135(5):530–4;discussion 4–5.PubMedGoogle Scholar
  34. 34.
    Cook AD, Single R, McCahill LE. Surgical resection of primary tumors in patients who present with stage IV colorectal cancer: an analysis of surveillance, epidemiology, and end results data, 1988 to 2000. Ann Surg Oncol. 2005;12(8):637–45.PubMedGoogle Scholar
  35. 35.
    Ruo L, Gougoutas C, Paty PB, Guillem JG, Cohen AM, Wong WD. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg. 2003;196(5):722–8.PubMedGoogle Scholar
  36. 36.
    Scoggins CR, Meszoely IM, Blanke CD, Beauchamp RD, Leach SD. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol. 1999;6(7):651–7.PubMedGoogle Scholar
  37. 37.
    Liu SK, Church JM, Lavery IC, Fazio VW. Operation in patients with incurable colon cancer – is it worthwhile? Dis Colon Rectum. 1997;40(1):11–4.PubMedGoogle Scholar
  38. 38.
    Konyalian VR, Rosing DK, Haukoos JS, Dixon MR, Sinow R, Bhaheetharan S, et al. The role of primary tumour resection in patients with stage IV colorectal cancer. Colorectal Dis. 2006;9:430–7.Google Scholar
  39. 39.
    Stillwell AP, Buettner PG, Ho YH. Meta-analysis of survival of patients with stage IV colorectal cancer managed with surgical resection versus chemotherapy alone. World J Surg. 2010;34(4):797–807.PubMedGoogle Scholar
  40. 40.
    Crane CH, Janjan NA, Abbruzzese JL, et al. Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancer. Int J Radiat Oncol Biol Phys. 2001;49(1):107–16.PubMedGoogle Scholar
  41. 41.
    Goere D, Deshaies I, De Baere T, et al. Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases. Ann Surg. 2010;251(4):686–91.PubMedGoogle Scholar
  42. 42.
    McCarter MD, Fong Y. Metastatic liver tumors. Semin Surg Oncol. 2000;19(2):177–88.PubMedGoogle Scholar
  43. 43.
    Fong Y. Surgical therapy of hepatic colorectal metastasis. CA Cancer J Clin. 1999;49(4):231–55.PubMedGoogle Scholar
  44. 44.
    Adam R, Avisar E, Ariche A, et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol. 2001;8(4):347–53.PubMedGoogle Scholar
  45. 45.
    Clavien PA, Selzner N, Morse M, Selzner M, Paulson E. Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy. Surgery. 2002;131(4):433–42.PubMedGoogle Scholar
  46. 46.
    Blumgart LH, Fong Y. Surgical options in the treatment of hepatic metastasis from colorectal cancer. Curr Probl Surg. 1995;32(5):333–421.PubMedGoogle Scholar
  47. 47.
    Wagner JS, Adson MA, Van Heerden JA, Adson MH, Ilstrup DM. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg. 1984;199(5):502–8.PubMedPubMedCentralGoogle Scholar
  48. 48.
    Wood CB, Gillis CR, Blumgart LH. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol. 1976;2(3):285–8.PubMedGoogle Scholar
  49. 49.
    Kronawitter U, Kemeny NE, Heelan R, Fata F, Fong Y. Evaluation of chest computed tomography in the staging of patients with potentially resectable liver metastases from colorectal carcinoma. Cancer. 1999;86(2):229–35.PubMedGoogle Scholar
  50. 50.
    Kim HC, Kim TK, Sung KB, et al. CT during hepatic arteriography and portography: an illustrative review. Radiographics. 2002;22(5):1041–51.PubMedGoogle Scholar
  51. 51.
    Poyanli A, Sencer S. Computed tomography scan of the liver. Eur J Radiol. 1999;32(1):15–20.PubMedGoogle Scholar
  52. 52.
    Hann LE, Winston CB, Brown KT, Akhurst T. Diagnostic imaging approaches and relationship to hepatobiliary cancer staging and therapy. Semin Surg Oncol. 2000;19(2):94–115.PubMedGoogle Scholar
  53. 53.
    Fong Y, Blumgart LH, Fortner JG, Brennan MF. Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg. 1995;222(4):426–34;discussion 34–7.PubMedPubMedCentralGoogle Scholar
  54. 54.
    D’Angelica MI, Shoup MC, Nissan A. Randomized clinical trials in advanced and metastatic colorectal carcinoma. Surg Oncol Clin N Am. 2002;11(1):173–91.Google Scholar
  55. 55.
    Rougier P, Van Cutsem E, Bajetta E, et al. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer. Lancet. 1998;352(9138):1407–12.PubMedGoogle Scholar
  56. 56.
    Cunningham D, Pyrhonen S, James RD, et al. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet. 1998;352(9138):1413–8.PubMedGoogle Scholar
  57. 57.
    Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med. 2000;343(13):905–14.PubMedGoogle Scholar
  58. 58.
    Douillard JY, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet. 2000;355(9209):1041–7.PubMedGoogle Scholar
  59. 59.
    Kuebler JP, de Gramont A. Recent experience with oxaliplatin or irinotecan combined with 5-fluorouracil and leucovorin in the treatment of colorectal cancer. Semin Oncol. 2003;30(4 Suppl 15):40–6.PubMedGoogle Scholar
  60. 60.
    de Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 2000;18(16):2938–47.PubMedGoogle Scholar
  61. 61.
    Goldberg RM, Morton RF, Sargent DJ, et al. N9741: oxaliplatin (oxal) or CPT-11 + 5-fluorouracil (5FU)/leucovorin (LV) or oxal + CPT-11 in advanced colorectal cancer (CRC). Initial toxicity and response data from a GI Intergroup study. Proc Am Soc Clin Oncol. 2002;21:128a;abstract 511.Google Scholar
  62. 62.
    Siena S, Sartore-Bianchi A, Di Nicolantonio F, et al. Biomarkers predicting clinical outcomes of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer. J Natl Cancer Inst. 2009;101(19):1308–24.PubMedPubMedCentralGoogle Scholar
  63. 63.
    Nicholson RI, Gee JM, Harper ME. EGFR and cancer prognosis. Eur J Cancer. 2001;37 Suppl 4:S9–15.PubMedGoogle Scholar
  64. 64.
    Tol J, Koopman M, Cats A, et al. Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. N Engl J Med. 2009;360(6):563–72.PubMedGoogle Scholar
  65. 65.
    Di Nicolantonio F, Martini M, Molinari F, et al. Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer. J Clin Oncol. 2008;26(35):5705–12.PubMedGoogle Scholar
  66. 66.
    Abdel-Misih SR, Schmidt CR, Bloomston PM. Update and review of the multidiciplinary management of stage IV colorectal cancer with liver metastases. World J Surg Oncol. 2009;7(72):2–14.Google Scholar
  67. 67.
    Ackerman NB, Lien WM, Kondi ES, Silverman NA. The blood supply of experimental liver metastases. I. The distribution of hepatic artery and portal vein blood to “small” and “large” tumors. Surgery. 1969;66(6):1067–72.PubMedGoogle Scholar
  68. 68.
    Oberfield RA, McCaffrey JA, Polio J, Clouse ME, Hamilton T. Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary. Cancer. 1979;44(2):414–23.PubMedGoogle Scholar
  69. 69.
    Weiss GR, Garnick MB, Osteen RT, et al. Long-term hepatic arterial infusion of 5-fluorodeoxyuridine for liver metastases using an implantable infusion pump. J Clin Oncol. 1983;1(5):337–44.PubMedGoogle Scholar
  70. 70.
    Balch CM, Urist MM, Soong SJ, McGregor M. A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg. 1983;198(5):567–73.PubMedPubMedCentralGoogle Scholar
  71. 71.
    Niederhuber JE, Ensminger W, Gyves J, Thrall J, Walker S, Cozzi E. Regional chemotherapy of colorectal cancer metastatic to the liver. Cancer. 1984;53(6):1336–43.PubMedGoogle Scholar
  72. 72.
    Harmantas A, Rotstein LE, Langer B. Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver. Is there a survival difference? Meta-analysis of the published literature. Cancer. 1996;78(8):1639–45.PubMedGoogle Scholar
  73. 73.
    Meta-Analysis Group in Cancer. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst. 1996;88(5):252–8.Google Scholar
  74. 74.
    Kemeny N, Niedzwiecki D, Hollis DR. Hepatic arterial infusion (HAI) versus systemic therapy for hepatic metastases from colorectal cancer: a CALGB randomized trial of efficacy, quality of life (QOL), cost effectiveness, and molecular markers. Proc Am Soc Clin Oncol. 2003;22:252;abstract 1010.Google Scholar
  75. 75.
    Mocellin S, Pasquali S, Nitti D. Fluoropyrimidine-HAI versus systemic chemotherapy for unresectable liver metastases from colorectal cancer. Cochran Collab. 2009;(3):CD007823.Google Scholar
  76. 76.
    Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg. 2002;236(4):397–406;discussion.PubMedPubMedCentralGoogle Scholar
  77. 77.
    Silen W. Hepatic resection for metastases from colorectal carcinoma is of dubious value. Arch Surg. 1989;124(9):1021–2.PubMedGoogle Scholar
  78. 78.
    Foster JH. Survival after liver resection for secondary tumors. Am J Surg. 1978;135(3):389–94.PubMedGoogle Scholar
  79. 79.
    D’Angelica M, Brennan MF, Fortner JG, Cohen AM, Blumgart LH, Fong Y. Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. J Am Coll Surg. 1997;185(6):554–9.PubMedGoogle Scholar
  80. 80.
    Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery. 1991;110(1):13–29.PubMedGoogle Scholar
  81. 81.
    Doci R, Gennari L, Bignami P, Montalto F, Morabito A, Bozzetti F. One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg. 1991;78(7):797–801.PubMedGoogle Scholar
  82. 82.
    Rosen CB, Nagorney DM, Taswell HF, et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg. 1992;216(4):493–504;discussion 5.PubMedPubMedCentralGoogle Scholar
  83. 83.
    Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230(3):309–18;discussion 18–21.PubMedPubMedCentralGoogle Scholar
  84. 84.
    Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol. 1997;15(3):938–46.PubMedGoogle Scholar
  85. 85.
    Choti MA, Sitzman JV, Tiburi MF, et al. Trends in long-term survival following liver resection of colorectal metastases. Ann Surg. 2002;235:759–66.PubMedPubMedCentralGoogle Scholar
  86. 86.
    Charnsangavej C, Clary B, Fong Y, et al. Selection of patients for resection for hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol. 2006;13:1261–8.PubMedGoogle Scholar
  87. 87.
    de Haas RJ, Wicherts DA, Flores E. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg. 2008;248:626–37.PubMedGoogle Scholar
  88. 88.
    Petrowsky H, Gonen M, Jarnagin W, et al. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg. 2002;235(6):863–71.PubMedPubMedCentralGoogle Scholar
  89. 89.
    Lorenz M, Muller HH, Schramm H, et al. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen). Ann Surg. 1998;228(6):756–62.PubMedPubMedCentralGoogle Scholar
  90. 90.
    Kemeny MM, Adak S, Gray B, et al. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy – an intergroup study. J Clin Oncol. 2002;20(6):1499–505.PubMedGoogle Scholar
  91. 91.
    Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med. 1999;341(27):2039–48.PubMedGoogle Scholar
  92. 92.
    Curley SA. Radiofrequency ablation of malignant liver tumors. Ann Surg Oncol. 2003;10(4):338–47.PubMedGoogle Scholar
  93. 93.
    Nordlinger B, Rougier P. Nonsurgical methods for liver metastases including cryotherapy, radiofrequency ablation, and infusional treatment: what’s new in 2001? Curr Opin Oncol. 2002;14(4):420–3.PubMedGoogle Scholar
  94. 94.
    Nicoly NH, Berry DP, Sharma RA. Liver metastases from colorectal cancer: radioembolization with systemic therapy. Nat Rev. 2009;6:687–97.Google Scholar
  95. 95.
    Dahabre J, Vasilaki M, Stathopoulos GP, Kondaxis A, Iliadis K, Papadopoulos G, et al. Surgical management in lung metastases from colorectal cancer. Anticancer Res. 2007;27(6C):4387–90.PubMedGoogle Scholar
  96. 96.
    McCormack PM, Attiyeh FF. Resected pulmonary metastases from colorectal cancer. Dis Colon Rectum. 1979;22(8):553–6.PubMedGoogle Scholar
  97. 97.
    McAfee MK, Allen MS, Trastek VF, Ilstrup DM, Deschamps C, Pairolero PC. Colorectal lung metastases: results of surgical excision. Ann Thorac Surg. 1992;53(5):780–5;discussion 5–6.PubMedGoogle Scholar
  98. 98.
    Nagakura S, Shirai Y, Yamato Y, Yokoyama N, Suda T, Hatakeyama K. Simultaneous detection of colorectal carcinoma liver and lung metastases does not warrant resection. J Am Coll Surg. 2001;193(2):153–60.PubMedGoogle Scholar
  99. 99.
    Dematteo R, Minnard EA, Kemeny N. Outcome after resection of both liver and lung metastases in patients with colorectal cancer. Proc Am Soc Clin Oncol. 1999;abstract 958.Google Scholar
  100. 100.
    Rizk NP, Downey RJ. Resection of pulmonary metastases from colorectal cancer. Semin Thorac Cardiovasc Surg. 2002;14(1):29–34.PubMedGoogle Scholar
  101. 101.
    Roth JA, Pass HI, Wesley MN, White D, Putnam JB, Seipp C. Comparison of median sternotomy and thoracotomy for resection of pulmonary metastases in patients with adult soft-tissue sarcomas. Ann Thorac Surg. 1986;42(2):134–8.PubMedGoogle Scholar
  102. 102.
    McCormack PM, Bains MS, Begg CB, et al. Role of video-assisted thoracic surgery in the treatment of pulmonary metastases: results of a prospective trial. Ann Thorac Surg. 1996;62(1):213–6;discussion 6–7.PubMedGoogle Scholar
  103. 103.
    Muacevic A, Drexler C, Wowra B, Schweikard A, Schlaefer A, Hoffmann RT, et al. Technical description, phantom accuracy, and clinical feasibility for single-session lung radiosurgery using robotic image-guided real-time respiratory tumor tracking. Technol Cancer Res Treat. 2007;6(4):321–8.PubMedGoogle Scholar
  104. 104.
    Sugarbaker PH, Cunliffe WJ, Belliveau J, et al. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol. 1989;16(4 Suppl 6):83–97.PubMedGoogle Scholar
  105. 105.
    Dawson LE, Russell AH, Tong D, Wisbeck WM. Adenocarcinoma of the sigmoid colon: sites of initial dissemination and clinical patterns of recurrence following surgery alone. J Surg Oncol. 1983;22(2):95–9.PubMedGoogle Scholar
  106. 106.
    Russell AH, Tong D, Dawson LE, et al. Adenocarcinoma of the retroperitoneal ascending and descending colon: sites of initial dissemination and clinical patterns of recurrence following surgery alone. Int J Radiat Oncol Biol Phys. 1983;9(3):361–5.PubMedGoogle Scholar
  107. 107.
    Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer. 1989;63(2):364–7.PubMedGoogle Scholar
  108. 108.
    Willett CG, Tepper JE, Cohen AM, Orlow E, Welch CE. Failure patterns following curative resection of colonic carcinoma. Ann Surg. 1984;200(6):685–90.PubMedPubMedCentralGoogle Scholar
  109. 109.
    Hansen E, Wolff N, Knuechel R, Ruschoff J, Hofstaedter F, Taeger K. Tumor cells in blood shed from the surgical field. Arch Surg. 1995;130(4):387–93.PubMedGoogle Scholar
  110. 110.
    Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88(2):358–63.PubMedGoogle Scholar
  111. 111.
    Jacquet P, Jelinek JS, Steves MA, Sugarbaker PH. Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer. 1993;72(5):1631–6.PubMedGoogle Scholar
  112. 112.
    González-Moreno S, González-Bayón L, Ortega-Pérez G, et al. Imaging of peritoneal carcinomatosis. Cancer J. 2009;15(3):184–9.PubMedGoogle Scholar
  113. 113.
    Gilly FN, Beaujard A, Glehen O, et al. Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: phase I–II study. Anticancer Res. 1999;19(3B):2317–21.PubMedGoogle Scholar
  114. 114.
    Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359–74.PubMedGoogle Scholar
  115. 115.
    Pestieau SR, Sugarbaker PH. Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management. Dis Colon Rectum. 2000;43(10):1341–6;discussion 7–8.PubMedGoogle Scholar
  116. 116.
    Jayne DG, Fook S, Loi C, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2002;89(12):1545–50.PubMedGoogle Scholar
  117. 117.
    Machover D. A comprehensive review of 5-fluorouracil and leucovorin in patients with metastatic colorectal carcinoma. Cancer. 1997;80(7):1179–87.PubMedGoogle Scholar
  118. 118.
    Sugarbaker PH. Colorectal carcinomatosis: a new oncologic frontier. Curr Opin Oncol. 2005;17(4):397–9.PubMedGoogle Scholar
  119. 119.
    Speyer JL. The rationale behind intraperitoneal chemotherapy in gastrointestinal malignancies. Semin Oncol. 1985;12(3 Suppl 4):23–8.PubMedGoogle Scholar
  120. 120.
    Sugarbaker PH, Graves T, DeBruijn EA, et al. Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. Cancer Res. 1990;50(18):5790–4.PubMedGoogle Scholar
  121. 121.
    Sugarbaker PH, Schellinx ME, Chang D, Koslowe P, von Meyerfeldt M. Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg. 1996;20(5):585–91;discussion 92.PubMedGoogle Scholar
  122. 122.
    Verwaal VJ, van Ruth S, Witkamp A, Boot H, van Slooten G, Zoetmulder FA. Long-term survival of peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol. 2005;12(1):65–71.PubMedGoogle Scholar
  123. 123.
    Verwaal VJ, Bruin S, Boot H, et al. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15(9):2426–32.PubMedGoogle Scholar
  124. 124.
    Elias D, Blot F, El Otmany A, et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer. 2001;92(1):71–6.PubMedGoogle Scholar
  125. 125.
    Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21(20):3737–43.PubMedGoogle Scholar
  126. 126.
    Ulbright TM, Roth LM, Stehman FB. Secondary ovarian neoplasia. A clinicopathologic study of 35 cases. Cancer. 1984;53(5):1164–74.PubMedGoogle Scholar
  127. 127.
    Omranipour R, Abasahl A. Ovarian metastases in colorectal cancer. Int J Gynecol Cancer. 2009;19(9):1524–8.PubMedGoogle Scholar
  128. 128.
    Webb MJ, Decker DG, Mussey E. Cancer metastatic to the ovary: factors influencing survival. Obstet Gynecol. 1975;45(4):391–6.PubMedGoogle Scholar
  129. 129.
    Barr SS, Valiente MA, Bacon HE. Rationale of bilateral oophorectomy concomitant with resection for carcinoma of the rectum and colon. Dis Colon Rectum. 1962;5:450–2.PubMedGoogle Scholar
  130. 130.
    Blamey S, McDermott F, Pihl E, Price AB, Milne BJ, Hughes E. Ovarian involvement in adenocarcinoma of the colon and rectum. Surg Gynecol Obstet. 1981;153(1):42–4.PubMedGoogle Scholar
  131. 131.
    Morrow M, Enker WE. Late ovarian metastases in carcinoma of the colon and rectum. Arch Surg. 1984;119(12):1385–8.PubMedGoogle Scholar
  132. 132.
    Cutait R, Lesser ML, Enker WE. Prophylactic oophorectomy in surgery for large-bowel cancer. Dis Colon Rectum. 1983;26(1):6–11.PubMedGoogle Scholar
  133. 133.
    Young-Fadok TM, Wolff BG, Nivatvongs S, Metzger PP, Ilstrup DM. Prophylactic oophorectomy in colorectal carcinoma: preliminary results of a randomized, prospective trial. Dis Colon Rectum. 1998;41(3):277–83;discussion 83–5.PubMedGoogle Scholar
  134. 134.
    Burt CA. Carcinoma of the ovaries secondary to cancer of the colon and rectum. Dis Colon Rectum. 1960;3:352–7.PubMedGoogle Scholar
  135. 135.
    Stearns Jr MW, Deddish MR. Five-year results of abdominopelvic lymph node dissection for carcinoma of the rectum. Dis Colon Rectum. 1959;2(2):169–72.PubMedGoogle Scholar
  136. 136.
    Graffner HO, Alm PO, Oscarson JE. Prophylactic oophorectomy in colorectal carcinoma. Am J Surg. 1983;146(2):233–5.PubMedGoogle Scholar
  137. 137.
    Koves I, Vamosi-Nagy I, Besznyak I. Ovarian metastases of colorectal tumours. Eur J Surg Oncol. 1993;19(6):633–5.PubMedGoogle Scholar
  138. 138.
    Harcourt KF, Dennis DL. Laparotomy for “ovarian tumors” in unsuspected carcinoma of the colon. Cancer. 1968;21(6):1244–6.PubMedGoogle Scholar
  139. 139.
    Lindner V, Gasser B, Debbiche A, Tomb L, Vetter JM, Walter P. Ovarian metastasis of colorectal adenocarcinomas. A clinico-pathological study of 41 cases. Ann Pathol. 1999;19(6):492–8.PubMedGoogle Scholar
  140. 140.
    Rayson D, Bouttell E, Whiston F, Stitt L. Outcome after ovarian/adnexal metastectomy in metastatic colorectal carcinoma. J Surg Oncol. 2000;75(3):186–92.PubMedGoogle Scholar
  141. 141.
    Loy TS, Calaluce RD, Keeney GL. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma. Mod Pathol. 1996;9(11):1040–4.PubMedGoogle Scholar
  142. 142.
    DeCostanzo DC, Elias JM, Chumas JC. Necrosis in 84 ovarian carcinomas: a morphologic study of primary versus metastatic colonic carcinoma with a selective immunohistochemical analysis of cytokeratin subtypes and carcinoembryonic antigen. Int J Gynecol Pathol. 1997;16(3):245–9.PubMedGoogle Scholar
  143. 143.
    Wauters CC, Smedts F, Gerrits LG, Bosman FT, Ramaekers FC. Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary. Hum Pathol. 1995;26(8):852–5.PubMedGoogle Scholar
  144. 144.
    Dionigi A, Facco C, Tibiletti MG, Bernasconi B, Riva C, Capella C. Ovarian metastases from colorectal carcinoma. Clinicopathologic profile, immunophenotype, and karyotype analysis. Am J Clin Pathol. 2000;114(1):111–22.PubMedGoogle Scholar
  145. 145.
    Blamey SL, McDermott FT, Pihl E, Hughes ES. Resected ovarian recurrence from colorectal adenocarcinoma: a study of 13 cases. Dis Colon Rectum. 1981;24(4):272–5.PubMedGoogle Scholar
  146. 146.
    Herrera-Ornelas L, Mittelman A. Results of synchronous surgical removal of primary colorectal adenocarcinoma and ovarian metastases. Oncology. 1984;41(2):96–100.PubMedGoogle Scholar
  147. 147.
    Huang PP, Weber TK, Mendoza C, Rodriguez-Bigas MA, Petrelli NJ. Long-term survival in patients with ovarian metastases from colorectal carcinoma. Ann Surg Oncol. 1998;5(8):695–8.PubMedGoogle Scholar
  148. 148.
    Wright JD, Powell MA, Mutch DG, et al. Synchronous ovarian metastases at the time of laparotomy for colon cancer. Gynecol Oncol. 2004;92(3):851–5.PubMedGoogle Scholar
  149. 149.
    Miller BE, Pittman B, Wan JY, Fleming M. Colon cancer with metastasis to the ovary at time of initial diagnosis. Gynecol Oncol. 1997;66(3):368–71.PubMedGoogle Scholar
  150. 150.
    MacKeigan JM, Ferguson JA. Prophylactic oophorectomy and colorectal cancer in premenopausal patients. Dis Colon Rectum. 1979;22(6):401–5.PubMedGoogle Scholar
  151. 151.
    Ballantyne GH, Reigel MM, Wolff BG, Ilstrup DM. Oophorectomy and colon cancer. Impact on survival. Ann Surg. 1985;202(2):209–14.PubMedPubMedCentralGoogle Scholar
  152. 152.
    Sielezneff I, Salle E, Antoine K, Thirion X, Brunet C, Sastre B. Simultaneous bilateral oophorectomy does not improve prognosis of postmenopausal women undergoing colorectal resection for cancer. Dis Colon Rectum. 1997;40(11):1299–302.PubMedGoogle Scholar
  153. 153.
    Kontoravdis A, Kalogirou D, Antoniou G, Kontoravdis N, Karakitsos P, Zourlas PA. Prophylactic oophorectomy in ovarian cancer prevention. Int J Gynaecol Obstet. 1996;54(3):257–62.PubMedGoogle Scholar
  154. 154.
    Barringer PL, Dockerty MB, Waugh JM, Bargen JA. Carcinoma of the large intestine; a new approach to the study of venous spread. Surg Gynecol Obstet. 1954;98(1):62–72.PubMedGoogle Scholar
  155. 155.
    Besbeas S, Stearns Jr MW. Osseous metastases from carcinomas of the colon and rectum. Dis Colon Rectum. 1978;21(4):266–8.PubMedGoogle Scholar
  156. 156.
    Buckley N, Peebles Brown DA. Metastatic tumors in the hand from adenocarcinoma of the colon. Dis Colon Rectum. 1987;30(2):141–3.PubMedGoogle Scholar
  157. 157.
    Cascino TL, Leavengood JM, Kemeny N, Posner JB. Brain metastases from colon cancer. J Neurooncol. 1983;1(3):203–9.PubMedGoogle Scholar
  158. 158.
    Rovirosa A, Bodi R, Vicente P, Alastuey I, Giralt J, Salvador L. Cerebral metastases in adenocarcinoma of the colon. Rev Esp Enferm Dig. 1991;79(4):281–3.PubMedGoogle Scholar
  159. 159.
    Zimm S, Wampler GL, Stablein D, Hazra T, Young HF. Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer. 1981;48(2):384–94.PubMedGoogle Scholar
  160. 160.
    Wronski M, Arbit E. Resection of brain metastases from colorectal carcinoma in 73 patients. Cancer. 1999;85(8):1677–85.PubMedGoogle Scholar
  161. 161.
    Ko FC, Liu JM, Chen WS, Chiang JK, Lin TC, Lin JK. Risk and patterns of brain metastases in colorectal cancer: 27-year experience. Dis Colon Rectum. 1999;42(11):1467–71.PubMedGoogle Scholar
  162. 162.
    Wowra B, Muacevic A, Tonn JC. Quality of radiosurgery for single brain metastases with respect to treatment technology: a matched-pair analysis. J Neurooncol. 2009;94(1):69–77.PubMedGoogle Scholar
  163. 163.
    Temple LK, Hsieh L, Wong WD, Saltz L, Schrag D. Use of surgery among elderly patients with stage IV colorectal cancer. J Clin Oncol. 2004;22(17):3475–84.PubMedGoogle Scholar
  164. 164.
    Mori M, Tomoda H, Ishida T, et al. Surgical resection of pulmonary metastases from colorectal adenocarcinoma. Special reference to repeated pulmonary resections. Arch Surg. 1991;126(10):1297–301;discussion 302.PubMedGoogle Scholar
  165. 165.
    McCormack PM, Burt ME, Bains MS, Martini N, Rusch VW, Ginsberg RJ. Lung resection for colorectal metastases. 10-year results. Arch Surg. 1992;127(12):1403–6.PubMedGoogle Scholar
  166. 166.
    Yano T, Hara N, Ichinose Y, Yokoyama H, Miura T, Ohta M. Results of pulmonary resection of metastatic colorectal cancer and its application. J Thorac Cardiovasc Surg. 1993;106(5):875–9.PubMedGoogle Scholar
  167. 167.
    Saclarides TJ, Krueger BL, Szeluga DJ, Warren WH, Faber LP, Economou SG. Thoracotomy for colon and rectal cancer metastases. Dis Colon Rectum. 1993;36(5):425–9.PubMedGoogle Scholar
  168. 168.
    van Halteren HK, van Geel AN, Hart AA, Zoetmulder FA. Pulmonary resection for metastases of colorectal origin. Chest. 1995;107(6):1526–31.PubMedGoogle Scholar
  169. 169.
    Shirouzu K, Isomoto H, Hayashi A, Nagamatsu Y, Kakegawa T. Surgical treatment for patients with pulmonary metastases after resection of primary colorectal carcinoma. Cancer. 1995;76(3):393–8.PubMedGoogle Scholar
  170. 170.
    Girard P, Ducreux M, Baldeyrou P, et al. Surgery for lung metastases from colorectal cancer: analysis of prognostic factors. J Clin Oncol. 1996;14(7):2047–53.PubMedGoogle Scholar
  171. 171.
    Okumura S, Kondo H, Tsuboi M, et al. Pulmonary resection for metastatic colorectal cancer: experiences with 159 patients. J Thorac Cardiovasc Surg. 1996;112(4):867–74.PubMedGoogle Scholar
  172. 172.
    Zanella A, Marchet A, Mainente P, Nitti D, Lise M. Resection of pulmonary metastases from colorectal carcinoma. Eur J Surg Oncol. 1997;23(5):424–7.PubMedGoogle Scholar
  173. 173.
    Zink S, Kayser G, Gabius HJ, Kayser K. Survival, disease-free interval, and associated tumor features in patients with colon/rectal carcinomas and their resected intra-pulmonary metastases. Eur J Cardiothorac Surg. 2001;19(6):908–13.PubMedGoogle Scholar
  174. 174.
    Israel SL, Helsel Jr EV, Hausman DH. The challenge of metastatic ovarian carcinoma. Am J Obstet Gynecol. 1965;93(8):1094–101.PubMedGoogle Scholar
  175. 175.
    Demopoulos RI, Touger L, Dubin N. Secondary ovarian carcinoma: a clinical and pathological evaluation. Int J Gynecol Pathol. 1987;6(2):166–75.PubMedGoogle Scholar

Copyright information

© ASCRS (American Society of Colon and Rectal Surgeons) 2011

Authors and Affiliations

  • Elisabeth C. McLemore
    • 1
  • Sonia Ramamoorthy
    • 2
  1. 1.Colon & Rectal Surgery, Moores Cancer CenterUniversity of California, San DiegoLa JollaUSA
  2. 2.Colon and Rectal SurgeryRebecca and John Moores Cancer CenterLa JollaUSA

Personalised recommendations